Latest On Genocea Biosciences, Inc (GNCA):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-05-24 19:05 EST | News | Genocea stock crashes 64% on winding down of operations, Nasdaq delisting | N/A |  |
| 2022-04-29 06:57 EST | News | Genocea stock plunges on cutting workforce by 65% and exploring sale or merger alternatives; Stifel cuts PT to $0.16 | N/A | |
| 2022-03-10 16:33 EST | News | Genocea Biosciences GAAP EPS of -$0.19 misses by $0.01 | N/A | |
| 2022-03-10 16:33 EST | News | Genocea Biosciences, Inc. (GNCA) CEO William Clark on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-10 00:07 EST | News | Genocea Biosciences Q4 2021 Earnings Preview | N/A | |
| 2021-10-28 22:08 EST | News | Genocea Biosciences EPS beats by $0.16 | N/A | |
| 2021-10-28 22:06 EST | News | Genocea Biosciences' (GNCA) CEO Chip Clark on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-10-27 19:01 EST | News | Genocea Biosciences Q3 2021 Earnings Preview | N/A | |
| 2021-10-13 01:25 EST | News | Warning: GNCA is at high risk of performing badly | N/A | |
| 2021-10-07 11:23 EST | News | GNCA is at high risk of performing badly | N/A | |
| 2021-10-06 07:55 EST | News | Warning: GNCA has been downgraded to Very Bearish | N/A | |
| 2021-09-29 15:51 EST | News | Genocea Biosciences up 7%; stock options granted to director | N/A | |
| 2021-07-29 19:11 EST | News | Genocea Biosciences, Inc. 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-07-29 19:08 EST | News | Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-21 09:54 EST | News | Genocea doses first patient in early-stage GEN-011 cancer study | N/A | |
| 2021-04-30 11:45 EST | News | Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2021-02-13 03:43 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-12 11:40 EST | Earnings Estimate | An EPS average of -$0.20 is estimated for the quarter ending on June 30, 2021. | Buy | |
| 2021-02-12 11:40 EST | Earnings Estimate | An EPS average of -$0.78 is estimated for the 2022 year. | Sell | |
| 2021-02-12 11:40 EST | Analyst Rating | The Analyst Target Price has decreased from $6.6 to $6.48. | Neutral | |
| 2021-02-12 01:29 EST | News | Genocea Biosciences EPS beats by $0.03 | N/A | |
| 2021-02-12 01:28 EST | News | Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-01-28 07:57 EST | News | Genocea (GNCA) shares rise 47% after reporting benefits of ATLAS platform in cancer study | N/A | |
| 2020-11-26 20:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-11 12:00 EST | Analyst Rating | The Analyst Target Price has decreased from $9.4 to $6.6. | Neutral | |
| 2020-11-07 15:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-05 03:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-02 03:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-31 17:00 EST | News | Genocea Biosciences EPS misses by $0.02 | N/A | |
| 2020-10-31 16:58 EST | News | Genocea Biosciences, Inc's (GNCA) CEO Chip Clark on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-10-31 04:52 EST | Earnings Estimate | An EPS average of -$0.22 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-09-26 12:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-23 05:51 EST | News | Genocea on go with early-stage study of cancer candidate GEN-011 | N/A | |
| 2020-09-18 05:44 EST | News | Genocea Biosciences announces follow-up data from GEN-009 Neoantigen Vaccine | N/A | |
| 2020-09-17 05:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-19 13:50 EST | News | Genocea -1.8% as holders file to offer 21.39M shares | N/A | |
| 2020-08-14 08:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-01 00:50 EST | Analyst Rating | The Analyst Target Price has decreased from $11.4 to $9.4. | Neutral | |
| 2020-07-31 01:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 22:07 EST | News | Genocea under pressure on underwhelming neoantigen vaccine data | N/A | |
| 2020-07-30 21:21 EST | Insider Trade | PLC GLAXOSMITHKLINE has indirectly acquired of 1,260,504 shares. | Buy | |
| 2020-07-28 17:36 EST | Insider Trade | New Enterprise Associates 16, L.P. has directly acquired 3,151,260 shares and currently holds 10,376,936 shares. | Buy | |
| 2020-07-28 17:36 EST | Insider Trade | FOREST BASKETT has indirectly acquired of 3,151,260 shares. | Buy | |
| 2020-07-28 17:36 EST | Insider Trade | Carmen Chang has indirectly acquired of 3,151,260 shares. | Buy | |
| 2020-07-28 17:36 EST | Insider Trade | Ali Behbahani has indirectly acquired of 3,151,260 shares. | Buy | |
| 2020-07-28 17:36 EST | Insider Trade | Anthony A. Jr. Florence has indirectly acquired of 3,151,260 shares. | Buy | |
| 2020-07-28 17:36 EST | Insider Trade | Mohamad Makhzoumi has indirectly acquired of 3,151,260 shares. | Buy | |
| 2020-07-28 17:36 EST | Insider Trade | JOSHUA MAKOWER has indirectly acquired of 3,151,260 shares. | Buy | |
| 2020-07-28 17:36 EST | Insider Trade | SCOTT D SANDELL has indirectly acquired of 3,151,260 shares. | Buy | |
| 2020-07-28 17:36 EST | Insider Trade | Peter W. Sonsini has indirectly acquired of 3,151,260 shares. | Buy | |
About Genocea Biosciences, Inc (GNCA):
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy using neoantigen-targeted peripheral cells for ATLAS identified anti-tumor antigens that are used to manufacture peripheral blood-derived tumor-specific T cell therapy; and GEN-009, a neoantigen vaccine candidate, delivering adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts.
General
- Name Genocea Biosciences, Inc
- Symbol GNCA
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 72
- Last Split Factor1:8
- Last Split Date2019-05-22
- Fiscal Year EndDecember
- IPO Date2014-02-05
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.genocea.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 100.03
- Price/Book (Most Recent Quarter) 17.4
- Enterprise Value Revenue 73.86
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.75
- Next Year EPS Estimate -$0.73
- Next Quarter EPS Estimate -$0.23
- Operating Margin -3458%
- Return on Assets -39%
- Return on Equity -257%
- Revenue 1.36 million
- Earnings Per Share -$2.38
- Revenue Per Share $0.03
- Gross Profit 1.36 million
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 156.81 million
- EBITDA -38193000
- Analyst Target Price $6.48
- Book Value Per Share $0.17
View More
Share Statistics
- Shares Outstanding 53.52 million
- Shares Float 29.32 million
- % Held by Insiders 698%
- % Held by Institutions 54.72%
- Shares Short 1.51 million
- Shares Short Prior Month 1.69 million
- Short Ratio 1.98
- Short % of Float 4%
- Short % of Shares Outstanding 3%
View More
Technicals
- Beta 2.18
- 52 Week High $5.75
- 52 Week Low $1.35
- 50 Day Moving Average 3.1
- 200 Day Moving Average 2.55
View More
Dividends
- Dividend Date 2019-05-22
- ExDividend Date N/A
- Dividend Yield 0%
View More
Genocea Biosciences, Inc (GNCA) Dividend Calendar:
GNCA's last dividend payment was made to shareholders on May 22, 2019.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Genocea Biosciences, Inc (GNCA) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-11 | $N/A | -$0.23 | -$0.21 | -10.58% |
| 2020-09-30 | 2020-10-29 | $N/A | -$0.08 | -$0.26 | 69.23% |
| 2020-06-30 | 2020-07-23 | $906000 | -$0.39 | -$0.40 | 1.89% |
| 2020-03-31 | 2020-04-30 | $N/A | -$0.46 | -$0.35 | -30.68% |
| 2019-12-31 | 2020-02-13 | $N/A | -$0.34 | -$0.39 | 12.82% |
| 2019-09-30 | 2019-10-24 | $N/A | -$0.28 | -$0.46 | 38.8% |
| 2019-06-30 | 2019-07-25 | $N/A | -$0.42 | -$0.66 | 36.12% |
| 2019-03-31 | 2019-04-30 | $N/A | -$1.20 | -$0.69 | -73.09% |
| 2018-12-31 | 2019-02-28 | $N/A | $0.03 | -$0.93 | 103.46% |
| 2018-09-30 | 2018-11-01 | $N/A | -$0.72 | -$0.84 | 14.29% |
| 2018-06-30 | 2018-08-02 | $N/A | -$0.40 | -$1.00 | 60% |
| 2018-03-31 | 2018-05-10 | $N/A | -$1.68 | -$1.06 | -58.49% |
| 2017-12-31 | 2018-02-15 | $N/A | -$2.96 | -$3.39 | 12.6% |
| 2017-09-30 | 2017-11-02 | $N/A | -$4.72 | -$4.27 | -10.62% |
| 2017-06-30 | 2017-08-09 | $N/A | -$4.32 | -$3.72 | -16.13% |
| 2017-03-31 | 2017-05-04 | $N/A | -$3.84 | -$4.36 | 11.93% |
| 2016-12-31 | 2017-02-16 | $235000 | -$4.48 | -$3.74 | -19.66% |
| 2016-09-30 | 2016-11-03 | $N/A | -$3.60 | -$3.55 | -1.53% |
| 2016-06-30 | 2016-08-04 | $-235000 | -$3.12 | -$3.50 | 10.95% |
| 2016-03-31 | 2016-05-05 | $235000 | -$2.80 | -$3.35 | 16.51% |
| 2015-12-31 | 2016-02-11 | $221000 | -$2.96 | -$3.20 | 7.5% |
| 2015-09-30 | 2015-11-05 | $213000 | -$0.37 | -$0.44 | 15.91% |
| 2015-06-30 | 2015-08-06 | $115000 | -$0.43 | -$0.51 | 15.69% |
| 2015-03-31 | 2015-05-07 | $121000 | -$0.64 | -$0.59 | -8.47% |
| 2014-12-31 | 2015-02-12 | $308000 | -$0.66 | -$0.55 | -20% |
| 2014-09-30 | 2014-11-06 | $N/A | -$0.53 | -$0.51 | -3.92% |
| 2014-06-30 | 2014-08-06 | $N/A | -$3.28 | -$3.12 | -5.13% |
| 2014-03-31 | 2014-05-06 | $N/A | -$6.08 | -$4.18 | -45.45% |
| 2013-12-31 | 2014-03-21 | $20000 | -$3.76 | -$12.56 | 70.06% |
Genocea Biosciences, Inc (GNCA) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Genocea Biosciences, Inc (GNCA) Chart:
Genocea Biosciences, Inc (GNCA) News:
Below you will find a list of latest news for Genocea Biosciences, Inc (GNCA) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Genocea Biosciences, Inc (GNCA) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Genocea Biosciences, Inc (GNCA) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919120038072/0001209191-20-038072-index.htm |
| 2019-04-15 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1457612/000000000019007147/0000000000-19-007147-index.htm |
| 2019-06-12 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1457612/000000000019009795/0000000000-19-009795-index.htm |
| 2020-08-26 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1457612/000000000020008031/0000000000-20-008031-index.htm |
| 2019-02-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1457612/000090342319000131/0000903423-19-000131-index.htm |
| 2019-02-25 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000090342319000132/0000903423-19-000132-index.htm |
| 2019-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000090342319000257/0000903423-19-000257-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1457612/000092189519000483/0000921895-19-000483-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1457612/000092189520000571/0000921895-20-000571-index.htm |
| 2019-02-22 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1457612/000107261319000114/0001072613-19-000114-index.htm |
| 2019-06-28 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1457612/000107261319000223/0001072613-19-000223-index.htm |
| 2020-08-03 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1457612/000107261320000252/0001072613-20-000252-index.htm |
| 2020-07-31 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1457612/000110465920089108/0001104659-20-089108-index.htm |
| 2019-02-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1457612/000119312519039139/0001193125-19-039139-index.htm |
| 2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011145/0001209191-19-011145-index.htm |
| 2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011148/0001209191-19-011148-index.htm |
| 2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011151/0001209191-19-011151-index.htm |
| 2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011154/0001209191-19-011154-index.htm |
| 2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011157/0001209191-19-011157-index.htm |
| 2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011160/0001209191-19-011160-index.htm |
| 2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011165/0001209191-19-011165-index.htm |
| 2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011167/0001209191-19-011167-index.htm |
| 2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011169/0001209191-19-011169-index.htm |
| 2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011170/0001209191-19-011170-index.htm |
| 2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011173/0001209191-19-011173-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038946/0001209191-19-038946-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038949/0001209191-19-038949-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038951/0001209191-19-038951-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038955/0001209191-19-038955-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038956/0001209191-19-038956-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038959/0001209191-19-038959-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038960/0001209191-19-038960-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038963/0001209191-19-038963-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038964/0001209191-19-038964-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038966/0001209191-19-038966-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038967/0001209191-19-038967-index.htm |
| 2019-07-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919119042781/0001209191-19-042781-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919120038072/0001209191-20-038072-index.htm |
| 2020-07-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043862/0001209191-20-043862-index.htm |
| 2020-07-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043864/0001209191-20-043864-index.htm |
| 2020-07-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043865/0001209191-20-043865-index.htm |
| 2020-07-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043866/0001209191-20-043866-index.htm |
| 2020-07-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043867/0001209191-20-043867-index.htm |
| 2020-07-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043868/0001209191-20-043868-index.htm |
| 2020-07-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043869/0001209191-20-043869-index.htm |
| 2020-07-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043870/0001209191-20-043870-index.htm |
| 2020-07-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043871/0001209191-20-043871-index.htm |
| 2020-07-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043872/0001209191-20-043872-index.htm |
| 2020-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1457612/000121390020003634/0001213900-20-003634-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1457612/000121390020003699/0001213900-20-003699-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1457612/000138713120001833/0001387131-20-001833-index.htm |
| 2020-02-28 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1457612/000138713120002354/0001387131-20-002354-index.htm |
| 2020-07-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000138713120006914/0001387131-20-006914-index.htm |
| 2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000016/0001457612-19-000016-index.htm |
| 2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000017/0001457612-19-000017-index.htm |
| 2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000018/0001457612-19-000018-index.htm |
| 2019-02-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000022/0001457612-19-000022-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000025/0001457612-19-000025-index.htm |
| 2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000027/0001457612-19-000027-index.htm |
| 2019-03-04 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000029/0001457612-19-000029-index.htm |
| 2019-03-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000031/0001457612-19-000031-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000034/0001457612-19-000034-index.htm |
| 2019-03-07 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000036/0001457612-19-000036-index.htm |
| 2019-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000038/0001457612-19-000038-index.htm |
| 2019-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000040/0001457612-19-000040-index.htm |
| 2019-03-28 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000043/0001457612-19-000043-index.htm |
| 2019-03-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000046/0001457612-19-000046-index.htm |
| 2019-03-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000047/0001457612-19-000047-index.htm |
| 2019-04-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000049/0001457612-19-000049-index.htm |
| 2019-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000058/0001457612-19-000058-index.htm |
| 2019-04-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000062/0001457612-19-000062-index.htm |
| 2019-04-30 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000065/0001457612-19-000065-index.htm |
| 2019-04-30 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000066/0001457612-19-000066-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000068/0001457612-19-000068-index.htm |
| 2019-05-10 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000070/0001457612-19-000070-index.htm |
| 2019-05-14 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000073/0001457612-19-000073-index.htm |
| 2019-05-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000077/0001457612-19-000077-index.htm |
| 2019-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000080/0001457612-19-000080-index.htm |
| 2019-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000082/0001457612-19-000082-index.htm |
| 2019-06-07 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000084/0001457612-19-000084-index.htm |
| 2019-06-17 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000086/0001457612-19-000086-index.htm |
| 2019-06-18 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000092/0001457612-19-000092-index.htm |
| 2019-06-18 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000093/0001457612-19-000093-index.htm |
| 2019-06-19 | S-1MEF | Registration adding securities to prior Form S-1 registration [Rule 462(b)] | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000097/0001457612-19-000097-index.htm |
| 2019-06-21 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000101/0001457612-19-000101-index.htm |
| 2019-07-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000109/0001457612-19-000109-index.htm |
| 2019-07-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000110/0001457612-19-000110-index.htm |
| 2019-07-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000111/0001457612-19-000111-index.htm |
| 2019-07-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000112/0001457612-19-000112-index.htm |
| 2019-07-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000113/0001457612-19-000113-index.htm |
| 2019-07-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000114/0001457612-19-000114-index.htm |
| 2019-07-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000120/0001457612-19-000120-index.htm |
| 2019-07-25 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000123/0001457612-19-000123-index.htm |
| 2019-10-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000129/0001457612-19-000129-index.htm |
| 2019-10-24 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000133/0001457612-19-000133-index.htm |
| 2019-10-24 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000134/0001457612-19-000134-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000137/0001457612-19-000137-index.htm |
| 2019-11-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000141/0001457612-19-000141-index.htm |
| 2019-11-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000144/0001457612-19-000144-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000003/0001457612-20-000003-index.htm |
| 2020-02-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000008/0001457612-20-000008-index.htm |
| 2020-02-13 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000015/0001457612-20-000015-index.htm |
| 2020-02-13 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000016/0001457612-20-000016-index.htm |
| 2020-02-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000018/0001457612-20-000018-index.htm |
| 2020-02-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000020/0001457612-20-000020-index.htm |
| 2020-04-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000025/0001457612-20-000025-index.htm |
| 2020-04-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000027/0001457612-20-000027-index.htm |
| 2020-04-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000029/0001457612-20-000029-index.htm |
| 2020-04-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000031/0001457612-20-000031-index.htm |
| 2020-04-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000033/0001457612-20-000033-index.htm |
| 2020-04-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000035/0001457612-20-000035-index.htm |
| 2020-04-06 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000037/0001457612-20-000037-index.htm |
| 2020-04-20 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000040/0001457612-20-000040-index.htm |
| 2020-04-20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000041/0001457612-20-000041-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000047/0001457612-20-000047-index.htm |
| 2020-04-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000049/0001457612-20-000049-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000052/0001457612-20-000052-index.htm |
| 2020-05-22 | DEFR14A | Revised definitive proxy soliciting materials | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000058/0001457612-20-000058-index.htm |
| 2020-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000059/0001457612-20-000059-index.htm |
| 2020-06-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000074/0001457612-20-000074-index.htm |
| 2020-06-02 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000076/0001457612-20-000076-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000077/0001457612-20-000077-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000078/0001457612-20-000078-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000079/0001457612-20-000079-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000080/0001457612-20-000080-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000082/0001457612-20-000082-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000083/0001457612-20-000083-index.htm |
| 2020-06-19 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000098/0001457612-20-000098-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000099/0001457612-20-000099-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000100/0001457612-20-000100-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000101/0001457612-20-000101-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000102/0001457612-20-000102-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000103/0001457612-20-000103-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000104/0001457612-20-000104-index.htm |
| 2020-06-19 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000105/0001457612-20-000105-index.htm |
| 2020-07-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000107/0001457612-20-000107-index.htm |
| 2020-07-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000111/0001457612-20-000111-index.htm |
| 2020-07-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000116/0001457612-20-000116-index.htm |
| 2020-07-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000120/0001457612-20-000120-index.htm |
| 2020-07-23 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000125/0001457612-20-000125-index.htm |
| 2020-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000127/0001457612-20-000127-index.htm |
| 2020-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000129/0001457612-20-000129-index.htm |
| 2020-08-03 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000130/0001457612-20-000130-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000132/0001457612-20-000132-index.htm |
| 2020-08-18 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000142/0001457612-20-000142-index.htm |
| 2020-08-26 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000144/0001457612-20-000144-index.htm |
| 2020-08-28 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000147/0001457612-20-000147-index.htm |
| 2020-09-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000153/0001457612-20-000153-index.htm |
| 2020-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000161/0001457612-20-000161-index.htm |
| 2020-10-29 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000170/0001457612-20-000170-index.htm |
| 2019-02-27 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1457612/000156761919005500/0001567619-19-005500-index.htm |
| 2019-05-13 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1457612/999999999519001101/9999999995-19-001101-index.htm |
| 2019-06-19 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1457612/999999999519001385/9999999995-19-001385-index.htm |
| 2020-08-28 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1457612/999999999520002308/9999999995-20-002308-index.htm |
Genocea Biosciences, Inc (GNCA) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genocea Biosciences, Inc (GNCA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 698%Institutional Ownership: 5472%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-07-24 | Ali Behbahani | Director | Buy | 3,151,260.00 | 2.25 | 7,090,335.00 | 10,376,936.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043865/0001209191-20-043865-index.htm |
| 2020-07-24 | Anthony A. Jr. Florence | 10% Share Holder | Buy | 3,151,260.00 | 2.25 | 7,090,335.00 | 10,376,936.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043867/0001209191-20-043867-index.htm |
| 2020-07-24 | Carmen Chang | 10% Share Holder | Buy | 3,151,260.00 | 2.25 | 7,090,335.00 | 10,376,936.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043866/0001209191-20-043866-index.htm |
| 2020-07-24 | FOREST BASKETT | 10% Share Holder | Buy | 3,151,260.00 | 2.25 | 7,090,335.00 | 10,376,936.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043864/0001209191-20-043864-index.htm |
| 2020-07-24 | JOSHUA MAKOWER | 10% Share Holder | Buy | 3,151,260.00 | 2.25 | 7,090,335.00 | 10,376,936.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043869/0001209191-20-043869-index.htm |
| 2020-07-24 | Mohamad Makhzoumi | 10% Share Holder | Buy | 3,151,260.00 | 2.25 | 7,090,335.00 | 10,376,936.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043868/0001209191-20-043868-index.htm |
| 2020-07-24 | New Enterprise Associates 16, L.P. | 10% Share Holder | Buy | 3,151,260.00 | 2.25 | 7,090,335.00 | 10,376,936.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043862/0001209191-20-043862-index.htm |
| 2020-07-24 | Paul Edward Walker | 10% Share Holder | Buy | 3,151,260.00 | 2.25 | 7,090,335.00 | 10,376,936.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043872/0001209191-20-043872-index.htm |
| 2020-07-24 | Peter W. Sonsini | 10% Share Holder | Buy | 3,151,260.00 | 2.25 | 7,090,335.00 | 10,376,936.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043871/0001209191-20-043871-index.htm |
| 2020-07-24 | SCOTT D SANDELL | 10% Share Holder | Buy | 3,151,260.00 | 2.25 | 7,090,335.00 | 10,376,936.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919120043870/0001209191-20-043870-index.htm |
| 2019-03-15 | William D Clark | President and CEO | Buy | 15,000.00 | 0.54 | 8,100.00 | 119,931.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000038/0001457612-19-000038-index.htm |
| 2020-04-02 | Diantha Duvall | CHIEF FINANCIAL OFFICER | Buy | 12,299.00 | 12,299.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000025/0001457612-20-000025-index.htm | ||
| 2020-04-02 | Girish N Aakalu | CHIEF BUSINESS OFFICER | Buy | 12,299.00 | 12,299.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000027/0001457612-20-000027-index.htm | ||
| 2020-04-02 | Thomas Andrew Davis | CHIEF MEDICAL OFFICER | Buy | 12,299.00 | 12,299.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000031/0001457612-20-000031-index.htm | ||
| 2020-04-02 | Jessica Baker Flechtner | Chief Scientific Officer | Buy | 15,536.00 | 15,536.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000029/0001457612-20-000029-index.htm | ||
| 2020-04-02 | Narinderjeet Singh | SENIOR VP, PS&M | Buy | 15,536.00 | 15,536.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000033/0001457612-20-000033-index.htm | ||
| 2020-06-01 | William D Clark | President and CEO | Buy | 27,344.00 | 27,344.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000078/0001457612-20-000078-index.htm | ||
| 2019-06-24 | PLC GLAXOSMITHKLINE | 10% Share Holder | Buy | 1,857,142.00 | 3.50 | 6,499,997.00 | 3,365,884.00 | https://www.sec.gov/Archives/edgar/data/1457612/000090342319000257/0000903423-19-000257-index.htm |
| 2019-02-14 | Ali Behbahani | Director | Buy | 9,948,269.00 | 0.47 | 4,688,619.18 | 34,948,269.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011154/0001209191-19-011154-index.htm |
| 2019-02-14 | Anthony A. Jr. Florence | 10% Share Holder | Buy | 9,948,269.00 | 0.47 | 4,688,619.18 | 34,948,269.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011160/0001209191-19-011160-index.htm |
| 2019-02-14 | Carmen Chang | 10% Share Holder | Buy | 9,948,269.00 | 0.47 | 4,688,619.18 | 34,948,269.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011157/0001209191-19-011157-index.htm |
| 2019-02-14 | DAVID M MOTT | 10% Share Holder | Buy | 9,948,269.00 | 0.47 | 4,688,619.18 | 34,948,269.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011169/0001209191-19-011169-index.htm |
| 2019-02-14 | FOREST BASKETT | 10% Share Holder | Buy | 9,948,269.00 | 0.47 | 4,688,619.18 | 34,948,269.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011151/0001209191-19-011151-index.htm |
| 2019-02-14 | JOSHUA MAKOWER | 10% Share Holder | Buy | 9,948,269.00 | 0.47 | 4,688,619.18 | 34,948,269.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011167/0001209191-19-011167-index.htm |
| 2019-02-14 | Mohamad Makhzoumi | 10% Share Holder | Buy | 9,948,269.00 | 0.47 | 4,688,619.18 | 34,948,269.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011165/0001209191-19-011165-index.htm |
| 2019-02-14 | New Enterprise Associates 16, L.P. | 10% Share Holder | Buy | 9,948,269.00 | 0.47 | 4,688,619.18 | 34,948,269.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011145/0001209191-19-011145-index.htm |
| 2019-02-14 | PETER J BARRIS | 10% Share Holder | Buy | 9,948,269.00 | 0.47 | 4,688,619.18 | 34,948,269.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011148/0001209191-19-011148-index.htm |
| 2019-02-14 | Peter W. Sonsini | 10% Share Holder | Buy | 9,948,269.00 | 0.47 | 4,688,619.18 | 34,948,269.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011173/0001209191-19-011173-index.htm |
| 2019-02-14 | SCOTT D SANDELL | 10% Share Holder | Buy | 9,948,269.00 | 0.47 | 4,688,619.18 | 34,948,269.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119011170/0001209191-19-011170-index.htm |
| 2020-07-24 | PLC GLAXOSMITHKLINE | 10% Share Holder | Buy | 1,260,504.00 | 2.25 | 2,836,134.00 | 4,626,389.00 | https://www.sec.gov/Archives/edgar/data/1457612/000138713120006914/0001387131-20-006914-index.htm |
| 2019-03-18 | Narinderjeet Singh | SENIOR VP, PS&M | Buy | 7,291.00 | 0.54 | 3,937.14 | 47,291.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000040/0001457612-19-000040-index.htm |
| 2020-04-02 | William D Clark | President and CEO | Buy | 50,783.00 | 50,783.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000035/0001457612-20-000035-index.htm | ||
| 2019-04-11 | Narinderjeet Singh | SENIOR VP, PS&M | Buy | 7,291.00 | 0.54 | 3,937.14 | 54,582.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000049/0001457612-19-000049-index.htm |
| 2019-05-08 | Narinderjeet Singh | SENIOR VP, PS&M | Buy | 7,291.00 | 0.54 | 3,937.14 | 61,873.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761219000068/0001457612-19-000068-index.htm |
| 2020-06-01 | Diantha Duvall | CHIEF FINANCIAL OFFICER | Buy | 6,623.00 | 6,623.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000079/0001457612-20-000079-index.htm | ||
| 2020-06-01 | Girish N Aakalu | CHIEF BUSINESS OFFICER | Buy | 6,623.00 | 6,623.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000077/0001457612-20-000077-index.htm | ||
| 2020-06-01 | Thomas Andrew Davis | CHIEF MEDICAL OFFICER | Buy | 6,623.00 | 6,623.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000082/0001457612-20-000082-index.htm | ||
| 2019-06-24 | Ali Behbahani | Director | Buy | 2,857,142.00 | 3.50 | 9,999,997.00 | 7,225,676.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038955/0001209191-19-038955-index.htm |
| 2019-06-24 | Anthony A. Jr. Florence | 10% Share Holder | Buy | 2,857,142.00 | 3.50 | 9,999,997.00 | 7,225,676.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038959/0001209191-19-038959-index.htm |
| 2019-06-24 | Carmen Chang | 10% Share Holder | Buy | 2,857,142.00 | 3.50 | 9,999,997.00 | 7,225,676.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038956/0001209191-19-038956-index.htm |
| 2019-06-24 | DAVID M MOTT | 10% Share Holder | Buy | 2,857,142.00 | 3.50 | 9,999,997.00 | 7,225,676.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038964/0001209191-19-038964-index.htm |
| 2019-06-24 | FOREST BASKETT | 10% Share Holder | Buy | 2,857,142.00 | 3.50 | 9,999,997.00 | 7,225,676.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038951/0001209191-19-038951-index.htm |
| 2019-06-24 | JOSHUA MAKOWER | 10% Share Holder | Buy | 2,857,142.00 | 3.50 | 9,999,997.00 | 7,225,676.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038963/0001209191-19-038963-index.htm |
| 2019-06-24 | Mohamad Makhzoumi | 10% Share Holder | Buy | 2,857,142.00 | 3.50 | 9,999,997.00 | 7,225,676.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038960/0001209191-19-038960-index.htm |
| 2019-06-24 | New Enterprise Associates 16, L.P. | 10% Share Holder | Buy | 2,857,142.00 | 3.50 | 9,999,997.00 | 7,225,676.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038946/0001209191-19-038946-index.htm |
| 2019-06-24 | PETER J BARRIS | 10% Share Holder | Buy | 2,857,142.00 | 3.50 | 9,999,997.00 | 7,225,676.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038949/0001209191-19-038949-index.htm |
| 2019-06-24 | Peter W. Sonsini | 10% Share Holder | Buy | 2,857,142.00 | 3.50 | 9,999,997.00 | 7,225,676.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038967/0001209191-19-038967-index.htm |
| 2019-06-24 | SCOTT D SANDELL | 10% Share Holder | Buy | 2,857,142.00 | 3.50 | 9,999,997.00 | 7,225,676.00 | https://www.sec.gov/Archives/edgar/data/1457612/000120919119038966/0001209191-19-038966-index.htm |
| 2020-06-01 | Jessica Baker Flechtner | Chief Scientific Officer | Buy | 8,365.00 | 8,365.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000083/0001457612-20-000083-index.htm | ||
| 2020-06-01 | Narinderjeet Singh | SENIOR VP, PS&M | Buy | 8,365.00 | 8,365.00 | https://www.sec.gov/Archives/edgar/data/1457612/000145761220000080/0001457612-20-000080-index.htm |